Therefore, in this study, the expression profile of LSM1 gene in breast cancer was mined and analysed through a multi‐omics strategy to analyse the biologic pathways and targets of drug candidates obtained by pharmacogenomic screening. This evidence concerns the gene LSM1 and breast carcinoma.